SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-267301
Filing Date
2020-10-09
Accepted
2020-10-09 17:03:17
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B5 d12215d424b5.htm 424B5 1064386
2 GRAPHIC g12215d0001_818392.jpg GRAPHIC 49429
3 GRAPHIC g12215d0002_818392.jpg GRAPHIC 48329
4 GRAPHIC g12215d0003_818392.jpg GRAPHIC 49383
5 GRAPHIC g12215g02q20.jpg GRAPHIC 33289
6 GRAPHIC g12215g05b00.jpg GRAPHIC 131603
7 GRAPHIC g12215g20n07.jpg GRAPHIC 20945
8 GRAPHIC g12215g41o83.jpg GRAPHIC 34113
9 GRAPHIC g12215g85t59.jpg GRAPHIC 128990
  Complete submission text file 0001193125-20-267301.txt   1747613
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234405 | Film No.: 201233830
SIC: 2834 Pharmaceutical Preparations